Vertex Pharmaceuticals (VRTX) stock
Vertex Pharmaceuticals technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 38.36 | Neutral |
| Stochastic %K (14, 3, 3) | 19.2 | Neutral |
| CCI (20) | -179.62 | Neutral |
| ADX (14) | 17.58 | Neutral |
| Awesome Oscillator | -15.02 | Sell |
| Momentum (10) | -7.22 | Sell |
| MACD (12, 26) | -3.384 | Sell |
| Stoch RSI (3, 3, 14, 14) | -0 | Neutral |
| Williams %R (14) | -78.22 | Neutral |
| Bull Bear Power | -29.74 | Sell |
| Ultimate Oscillator (7, 14, 28) | 47.57 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | $514.40 | Sell |
| SMA (10) | $517.21 | Sell |
| EMA (20) | $518.26 | Sell |
| SMA (20) | $516.75 | Sell |
| EMA (30) | $518.68 | Sell |
| SMA (30) | $527.50 | Sell |
| EMA (50) | $514.03 | Sell |
| SMA (50) | $518.73 | Sell |
| EMA (100) | $498.65 | Buy |
| SMA (100) | $491.51 | Buy |
| EMA (200) | $479.96 | Buy |
| SMA (200) | $473.86 | Buy |
| Ichimoku Base Line (9, 26, 52, 26) | $528.20 | Sell |
| VWMA (20) | $515.96 | Sell |
| Hull MA (9) | $503.59 | Sell |
Support & resistance levels
Resistance
- R3$557.98+10.82%Moderate
- R2$546.17+8.47%Weak
- R1$531.68+5.60%Moderate
Support
- S1$496.98-1.30%Strong
- S2$465.86-7.48%Strong
- S3$450.12-10.60%Strong
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | $490.40 | $495.18 | $499.95 | $504.73 | $509.50 | $514.28 | $519.05 |
| Fibonacci | $495.18 | $498.82 | $501.08 | $504.73 | $508.37 | $510.63 | $514.28 |
| Camarilla | $502.10 | $502.98 | $503.85 | $504.73 | $505.61 | $506.48 | $507.36 |
| Woodie | $490.41 | $495.18 | $499.96 | $504.73 | $509.51 | $514.28 | $519.05 |
| DeMark | — | — | $497.57 | $503.53 | $507.12 | — | — |
Vertex Pharmaceuticals price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | $466.98 | $485.95 | $505.68 +0.4% | $526.22 | $547.60 |
| 21 trading days | $435.53 | $472.56 | $512.74 +1.8% | $556.33 | $603.63 |
| 63 trading days | $400.80 | $461.64 | $531.72 +5.6% | $612.44 | $705.42 |
The technical bias for Vertex Pharmaceuticals is bearish (overall rating: Sell).
Bullish scenario: a sustained break above $531.68 would open the way toward $546.17.
Bearish scenario: a daily close below $496.98 could extend the decline toward $465.86.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About Vertex Pharmaceuticals
Vertex Pharmaceuticals (VRTX) shares are trading at $503.50, down -0.24% today. The company belongs to the Health Care sector and has a market capitalization of $127.62B.
The stock’s 52-week range is $400.74 – $560.25, with a price-to-earnings ratio of 29.3. It has moved -3.61% over the past week and -8.13% over the past month.
On the daily chart the overall technical rating for Vertex Pharmaceuticals is Sell, with the 14-day RSI at 38.4. The nearest support is at $496.98 and the nearest resistance at $531.68.
Related markets
AllStock market news
-
Stock Market: Will S&P 500 Open Up or Down Today?Benzinga1 hr. ago
-
13 S&P 500 Stocks Hit 52-Week Lows On MondayTrefis1 hr. ago
-
Stocks At 52-Week Lows: Monday’s Full ListTrefis1 hr. ago
-
25 Small Cap Stocks Just Made New 52-Week HighsTrefis2 hr. ago
-
Moat Stocks Retreat As Market Breadth NarrowsSeeking Alpha2 hr. ago
-
Best Income Stocks to Buy for October 6thYahoo Finance2 hr. ago